Precigen to present at the 43rd annual j.p. morgan healthcare conference

Germantown, md. , jan. 9, 2025 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced helen sabzevari, phd, president and ceo of precigen, will present at the 43rd annual j.p.
PGEN Ratings Summary
PGEN Quant Ranking